Wlasciwosci wirusa i odpornosc przeciw PRRS

• Autorzy: Truszczynski M , Pejsak Z.

Warianty tytułu

EN

Virus properties and immunity against PRRS

• Języki publikacji: PL

Abstrakty

EN

Special attention in this review is given to published work on genetic, antigenic and pathogenic variations of the virus of porcine reproductive and respiratory syndrome (PRRS) and the potential implications of these properties for vaccine efficacy. Genomic organization of type 1 and type 2 strains of the PRRS virus is presented: the former being the representative of the European strains and the latter of the North American isolates. Among the European isolates 4 subtypes are differentiated. More homogenous are the strains of the Northern American type. Despite very high differences in antigenic properties of both European and North American isolates, it is possible to differentiate them, using serological methods, particularly the immunofluorescence test. The ELISA test proved to be useful in diagnosis of PRRS. However, antigens of the PRRS virus are of no use in the selection of strains for vaccine production. The high degree of variation among PRRS virus isolates is also demonstrated in pathogenic properties. Generally, the heterogeneity of genetic, antigenic and pathogenic properties, being a continuous process, is the explanation for the persistent infections resulting from the selection of mutants that escape neutralizing antibodies or cytotoxic T lymphocytes. Because of the heterogeneity of the mentioned biological properties of the field strains, the immunoprophylactic value of the available vaccines is not high. Better results are obtained when live, attenuated vaccines are used. In relation to this topic the proposition of Mengeling, called SWINE, is presented. The first letter means sensitization of the pig by vaccine injection; the second letter means waiting for more than several weeks until the level of neutralizing antibodies reaches low values; the letter I means immunization; N means neutralization of the virus; the letter E means eradication, in other words the elimination of PRRS. The last step must be supported by biosecurity and additional veterinary measures. Another method of immunoprophylaxis is the vaccination of pigs introduced to a herd using viremic serum of pigs of the same herd, which provides the best homogeneity of immunity and the highest efficacy.

Słowa kluczowe

PL

wirus PRRS; trzoda chlewna; odpornosc zwierzat; zespol rozrodczo-oddechowy; immunoprofilaktyka

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 12
• Opis fizyczny: s.1515-1518,bibliogr.

Twórcy

autor

Truszczynski M

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Pejsak Z.

Bibliografia

• 1.Allende R., Lewis T. L., Lu Z., Rock D. L., Kutish G. F., Ali A., Doster A. R., Osorio F. A.: North American and European porcine reproductive and respiratory syndrome viruses differ in nonstructural protein coding regions. J. Gen. Virol. 1999, 80, 307-315.
• 2.Anon.: International PRRS Symposium, Chicago, Illinois, USA, December 1-2, 2006.
• 3.Bautista E. M., Goyal S. M., Collins J. E.: Serological survey for Lelystad and VR-2332 strains of porcine respiratory and reproductive syndrome (PRRS) virus in US swine herds. J. Vet. Diagn. Invest. 1993, 5, 612-614.
• 4.Benfield D. A., Nelson F., Collins J. E., Harris E., Goyal S. M., Robinson D., Christionson W. T., Morrison R. B., Gorcyca D., Chladek D.: Characterization of swine infertility and respiratory syndrome (SIRS) virus (Isolate ATCC VR-2332). J. Vet. Diagn. Invest. 1992, 4, 127-133.
• 5.Bøtner A., Strandbygaard B., Sørensen K. J., Have P., Madsen K. G., Madsen E. S., Alexandersen S.: Appearance of PRRS-like symptoms in sow herds after vaccination with a modified PRRS vaccine. Vet. Rec. 1997, 141, 497-499.
• 6.Bøtner A., Strandbygard B., Sørensen K. J., Have P., Madsen E. S., Alexandersen S.: Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet. Rec. 1997, 141, 497-499.
• 7.Cavanagh D.: Nidovirales: A new order comprising Coronaviridae and Arteriviridae. Arch. Virol. 1997, 142, 629-633.
• 8.Domingo E., Baranowski E., Ruiz-Jarabo C. M., Martin-Hernandez A. M., Saiz J. C., Escarmis C.: Quasispecies structure and persistence of RNA virus. Emerging Infect. Dis. 1998, 4, 521-527.
• 9.Fang Y., Kim D.-Y., Ropp S., Steen P., Christopher-Hennings J., Nelson E. A., Rowland R. R. R.: Heterogeneity in Nsp 2 of European-like porcine reproductive and respiratory syndrome viruses isolated in the United States. Virus Res. 2004, 100, 229-235.
• 10.Fano E., Olea L., Pijoan C.: Eradication of porcine reproductive and respiratory syndrome virus by serum inoculation of naive gilts. Can. J. Vet. Res. 2005, 69, 71-74.
• 11.Halbur P. G., Paul P. S., Frey M. L., Landgraf J., Ernisse K., Meng X. J., Lum M. A., Andrews J. J., Rathje J. A.: Comparison of the pathogenicity of two U.S. porcine reproductive and respiratory syndrome virus isolated with that of the Lelystad virus. Vet. Pathol. 1995, 32, 648-660.
• 12.Halbur P. G., Paul P. S., Meng X. J., Lum M. A., Andrews J. J., Rathje J. A.: Comparative pathogenicity of nine U.S. porcine reproductive and respiratory syndrome virus (PRRSV) isolates in a five-week old cesareanderived colostrum deprived pig model. J. Vet. Diagn. Invest. 1996, 8, 11-20.
• 13.Juillard V., Piras F., Andreoni C., Charreyre C., Joisel E.: PRRSV-specific cell response following PRRSV infection and/or vaccination with an inactivated PRRS vaccine. Characterization of the PRRSV-specific responding cells. Proc. 18th Internat. Pig Veterinary Society Congress, Hamburg 2004, s. 138.
• 14.Labarque G., Reeth K. V., Nauwynck H., Drexler C., Van Gucht S., Pensaert M.: Impact of genetic diversity of European type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine 2004, 22, 4183-4190.
• 15.Lopez J. V., Oritz A.: Clinical and epidemiological effect of the vaccination with Porcilis PRRS in a sow herd with an active PRRS virus circulation. Proc. 18th Internat. Pig Veterinary Society Congress, Hamburg 2004, s. 114.
• 16.Mateu E., Tello M., Coll A., Casal J., Martin M.: Comparison of three ELISAs for the diagnosis of porcine reproductive and respiratory syndrome. Vet. Rec. 2006, 159, 717-718.
• 17.Meng X. J.: Heterogenicity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet. Microbiol. 2000, 74, 309-329.
• 18.Mengeling W. L.: PRRS vaccinology: Past, present and future. Proc. of American Association of Swine Veterinarians (A.A.S.V.). Toronto 5-8 March 2005, s. 284-304.
• 19.Mengeling W. L., Lager K. M., Vorwald A. C., Koehler K. J.: Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus. Vet. Microbiol. 2003, 93, 13-24.
• 20.Mengeling W. L., Vorwald A. C., Lager K. M., Brockmeier S. L.: Comparison among strains of porcine reproductive and respiratory syndrome virus for their ability to cause reproductive failere. Am. J. Vet. Res. 1996, 57, 834-839.
• 21.Mengeling W. L., Vorwald A. C., Lager K. M., Clouser D. F., Wesley R. D.: Identification and clinical assessment of suspected vaccine related field strains of porcine reproductive and respiratory syndrome virus. Am. J. Vet. Res. 1999, 60, 334-340.
• 22.Mondaca-Fernandez E., Morrison S., Dee S., Deen J., Davies P.: Area based of PRRSV and the initiation of a regional control program. Proc. 18th Internat. Pig Veterinary Society Congress, Hamburg 2004, s. 104.
• 23.Nelsen C. J., Murtaugh M. P., Faaberg K. S.: Porcine reproductive and respiratory syndrome virus comparison: Divergent evolution on two continents. J. Virol. 1999, 73, 270-280.
• 24.Neumann E. J., Kliebenstein J. B., Johnson C. D., Mabry E. J., Seitzinger A. H., Green A. L., Zimmerman J. I.: Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J. Am. Vet. Med. Assoc. 2005, 227, 385-392.
• 25.Nielsen H. S., Oleksiewicz M. B., Forsberg R., Stadejek T., Botner A., Storgaard T.: Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J. Gen. Virology 2001, 82, 1263- -1272.
• 26.Pejsak Z., Janicka K., Stadejek T.: Zastosowanie profilaktyki swoistej i nieswoistej w ograniczaniu strat spowodowanych przez zespół rozrodczo-oddechowy świñ. Medycyna Wet. 2005, 61, 417-421.
• 27.Pejsak Z., Markowska-Daniel I.: Randomised, placebo controlled trial of a live vaccine against porcine reproductive and respiratory syndrome virus in sows on infected farms. Vet. Rec. 2006, 158, 475.
• 28.Pejsak Z., Truszczyñski M.: Profilaktyka I zwalczanie zespołu rozrodczo-oddechowego świñ. Życie Wet. 2005, 80, 392-395.
• 29.Rossow K. D., Shivers J. L., Yeske P. E., Polson D. D., Rowland R. R., Lawson S. R., Murtaugh M. P., Nelson E. A., Collins J. E.: Porcine reproductive and respiratory syndrome virus infection in neonatal pigs characterized by marked neurovirulence. Vet. Rec. 1999, 144, 444-448.
• 30.Seesing E. H. A. L., van der Steen A., de Wit T., Joisel E., Longo S.: Field evaluation of vaccination against PRRS withy an inactivated PRRS vaccine in a Dutch breeding herd. Proc. 18th Internat. Pig Veterinary Society Congress, Hamburg 2004, s. 110.
• 31.Stadejek T.: Znaczenie zakażeñ przetrwałych wirusem zespołu rozrodczo-oddechowego świñ (PRRSV). Weterynaria po Dyplomie 2003, 4, 62-66.
• 32.Stadejek T., Oleksiewicz M. B., Potapchuk D., Podgorska K.: Porcie reproductive and respiratory syndrome virus strains of exceptional diversity in eastern Europe support the definition of new genetic subtypes. J. Gen. Virology 2006, 87, 1835-1841.
• 33.Stadejek T., Stankevicius A., Storgaard T., Oleksiewicz M. B., Belák S., Drew T. W., Pejsak Z.: Identification of radically different variants of porcine reproductive and respiratory syndrome virus in Eastern Europe: towards a common ancestor for European and American viruses. J. Gen. Virology 2002, 83, 1861-1873.
• 34.Stadejek T., Stankiewicz I., Pejsak Z.: Krążenie dwóch genotypów wirusa zespołu rozrodczo-oddechowego świñ (PRRSV) w stadzie œwiñ w Polsce. Medycyna Wet. 2005, 61, 321-325.
• 35.Storgaard T., Oleksiewicz M. B., Botner A.: Examination of the selective pressures on a liver PRRS vaccine virus. Arch. Virol. 1999, 144, 2389.
• 36.Van Woensel P. A., Liefkens K., Demaret S.: European serotype PRRSV vaccine protects against European serotype challenge whereas an American serotype vaccine does not. Adv. Exp. Med. Biol. 1998, 440, 713-718.
• 37.Wensvoort G.: Lelystad virus and the porcine epidemic abortion and respiratory syndrome. Vet. Rec. 1993, 24, 117-124.
• 38.Wensvoort G., Terpstra C., Pol J. M., ter Laak E. A., Bloemrad M., de Kluyer E. P., Kragten C., van Buiten L., den Besten A., Wagenaar F., Broekhujsen J. M., Moonen P. L. J. M., Zetstra T., Le Boer E. A., Tibben H. J., de Jong M. F., van’t Veld P., Groenland G. J. R., van Gennep J. A., Voets M. T. H., Verheijden J. H. M., Braamskamp J.: Mystery swine disease in the Netherlands: the isolation of Lelystad virus. Vet. Quarterly 1991, 13, 121-130.
• 39.Wesley R. D., Lager K. M., Kehrli M. E.: PRRSV infection stimulates an immediate serum interferon-gamma response. Proc. 18th Internat. Pig Veterinary Society Congress, Hamburg 2004, s. 90.
• 40.Wesley R. D., Mengeling W. L., Lager K. M., Clouser D. F., Landgraf J. G., Frey M. L.: Differentiation of a porcine reproductive and respiratory syndrome virus vaccine strain from North American field strains by restriction fragment length polymorphism analysis of ORF5. J. Vet. Diagn. Invest. 1998, 10, 140-144.
• 41.Wootton S., Yoo D., Rogan D.: Fool-length sequence of a Canadian porcine reproductive and respiratory syndrome virus (PRRSV) isolate. Arch. Virol. 2000, 145, 2297-2323.
• 42.Zimmerman J., Benfield D. A., Murtaugh M. P., Osorio F., Stevenson G. W., Torremorell M.: Porcine reproductive and respiratory syndrome virus (Porcine arterivirus, [w:] Straw B. E.: Diseases of Swine. Blackwell Publishing, Ames, Iowa 2006, s. 387.